Average Co-Inventor Count = 7.59
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. The Broad Institute, Inc. (17 from 443 patents)
2. The General Hospital Corporation (10 from 2,882 patents)
3. Massachusetts Institute of Technology (9 from 8,369 patents)
4. Dana-farber-cancer Institute Inc. (4 from 1,206 patents)
5. Biogen Ma Inc. (2 from 250 patents)
6. Harvard College (1 from 2,961 patents)
7. The General Hospital Corporation D/b/a Massachusetts General Hospital (1 patent)
18 patents:
1. 12486289 - Tricyclic compounds as glycogen synthase kinase 3 (GSK3) inhibitors and uses thereof
2. 12428373 - Dopamine D2 receptor ligands
3. 12419885 - Kinase inhibitors and methods of use thereof
4. 11572368 - Inhibitors of histone deacetylase
5. 11498896 - Dopamine D2 receptor ligands
6. 11203601 - Tricyclic compounds as glycogen synthase kinase 3 (GSK3) inhibitors and uses thereof
7. 11052080 - Kinase inhibitors and methods of use thereof
8. 10793538 - Cycloalkenyl hydroxamic acid derivatives and their use as histone deacetylase inhibitors
9. 10752588 - Dopamine D2 receptor ligands
10. 10662199 - Inhibitors of histone deacetylase
11. 10633336 - Dopamine D2 receptor ligands
12. 10137122 - Kinase inhibitors and methods of use thereof
13. 9914717 - Cycloalkenyl hydroxamic acid derivatives and their use as histone deacetylase inhibitors
14. 9890172 - Inhibitors of histone deacetylase
15. 9447030 - Inhibitors of histone deacetylase